AccuRna to provide a presentation at the 2019 AsiaTides in Japan

AccuRna Inc., a pre-clinical stage biotechnology company in the field of RNA-based drugs, today announced that Shiro Akinaga, Chief Executive Officer, will present a corporate overview at the 2019 AsiaTides in Japan on Thursday 28 February 2019 11:30am-12:00pm

For further information, please visit the website below.

https://lifesciences.knect365.com/asia-tides/agenda/3#oligonucleotide-track-delivery-strategies_emerging-rna-therapeutics-delivery-approaches-for-mrna-sirna-and-beyond